Systematic review of mathematical models exploring the epidemiological impact of future TB vaccines
- PMID: 27448625
- PMCID: PMC5137531
- DOI: 10.1080/21645515.2016.1205769
Systematic review of mathematical models exploring the epidemiological impact of future TB vaccines
Abstract
Mathematical models are useful for assessing the potential epidemiological impact of future tuberculosis (TB) vaccines. We conducted a systematic review of mathematical models estimating the epidemiological impact of future human TB vaccines. PubMed, Embase and WHO Global Health Library were searched, 3-stage manual sifted, and citation- and reference-tracked, identifying 23 papers. An adapted quality assessment tool was developed, with a resulting median study quality score of 20/28. The literature remains divided as to whether vaccines effective pre- or post-infection would provide greatest epidemiological impact. However, all-age or adolescent/adult targeted prevention of disease vaccines achieve greater and more rapid impact than neonatal vaccines. Mass campaigns alongside routine neonatal vaccination can have profound additional impact. Economic evaluations found TB vaccines overwhelmingly cost-effective, particularly when targeted to adolescents/adults. The variability of impact by setting, age group and vaccine characteristics must be accounted for in the development and delivery of future TB vaccines.
Keywords: epidemiology; infectious disease dynamics; mathematical model; systematic review; theoretical models; tuberculosis; vaccines.
Figures
References
-
- Abubakar I, Pimpin L, Ariti C, Beynon R, Mangtani P, Sterne JA, Fine PE, Smith PG, Lipman M, Elliman D, et al.. Systematic review and meta-analysis of the current evidence on the duration of protection by bacillus Calmette-Guerin vaccination against tuberculosis. Health Technol Assessment (Winchester, England) 2013; 17:1-372, v-vi. - PMC - PubMed
-
- Mangtani P, Abubakar I, Ariti C, Beynon R, Pimpin L, Fine PEM, Rodrigues LC, Smith PG, Lipman M, Whiting PF, et al.. Protection by BCG against tuberculosis: a systematic review of randomised controlled trials. Clin Infect Dis 2014; 58(4):470-80; PMID:24336911; http://dx.doi.org/10.1093/cid/cit790 - DOI - PubMed
-
- World Health Organization. Global Tuberculosis Report 2015. Geneva, Switzerland, 2015. http://www.who.int/tb/publications/global_report/en/ Accessed: 30thJanuary2016.
-
- Dye C, Glaziou P, Floyd K, Raviglione M. Prospects for tuberculosis elimination. Annu Rev Public Health 2013; 34:271-86; PMID:23244049; http://dx.doi.org/10.1146/annurev-publhealth-031912-114431 - DOI - PubMed
-
- World Health Organization The End TB Strategy. World Health Organization, 2015. http://www.who.int/tb/post2015_strategy/en/ Accessed: 30thJanuary2016.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical